http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2024, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Mon, 17 Jun 2024 20:39:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Press+Releases/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html <p align="justify">MELBOURNE, Australia, June 18, 2024 (GLOBE NEWSWIRE) -- CLINUVEL today announced a novel clinical program evaluating afamelanotide as a treatment in early-stage Parkinson’s Disease (PD or Parkinson’s) in fair-skinned patients. The program objectives are to determine whether afamelanotide – through melanocortin-1 receptor (MC1R) activation – is able to lower α-synuclein (a toxin) in blood levels in PD patients, and positively affect neurons of the midbrain. MC1R is known to be a key receptor in brain and skin cells.<br/></p> <p align="justify">In large studies, it was found that fair-skinned patients have a higher risk of PD http://www.streetinsider.com/Globe+Newswire/Afamelanotide+in+fair-skinned+Parkinson%E2%80%99s+patients/23368002.html Mon, 17 Jun 2024 20:39:00 -0400 CLVLY CUV O.00706064 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Press+Releases/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9 http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html <p>MALIBU, Calif., March 04, 2024 (GLOBE NEWSWIRE) -- Leading biotech company CLINUVEL last week joined an intimate event bringing together California’s most prolific investors and philanthropists at the Malibu home of Lady Gaga and Michael Polansky.</p> <p>The event, hosted by Lady Gaga and Mr. Polansky, and Sean Parker and Alexandra Parker, shone a light on the groundbreaking work of CLINUVEL, a global biopharmaceutical firm whose cutting-edge melanocortin therapies transform the lives of patients at the highest risk of photodamage and skin cancer. Mr. Parker and Mr. Polansky have supported CLINUVEL for more than 15 years, finding alignment http://www.streetinsider.com/Globe+Newswire/Malibu+shines+a+light+on+CLINUVEL%E2%80%99s+pioneering+work+in+photomedicine/22880999.html Mon, 04 Mar 2024 21:38:00 -0400 A.06822034 A.37922889 CLVLY CUV O.00706064 O.20026344 O.37378477 UR9 UR9